SCHEMBL20914099

SCHEMBL20914099

COc1cc(CO)cc2oc(-c3c(C)[nH]c4c(-c5ccccc5)c(C(F)(F)F)nn4c3=O)nc12

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ ARF6 P62330 6/20 0.34
▸ ALDH1A1 P00352 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ MAT2A P31153 2/20 0.32
▸ F2RL3 Q96RI0 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ DCTPP1 Q9H773 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ THRB P10828 1/20 0.31
▸ BLM P54132 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ PGR P06401 1/20 0.31
▸ KCNQ3 O43525 1/20 0.31
▸ KCNQ2 O43526 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20914200 0.92 KDM4E (0.35) POLBKDM4EARF6ALDH1A1MEN1
SCHEMBL20931227 0.90 KDM4E (0.35) POLBKDM4EARF6ALDH1A1MAT2A
SCHEMBL20914011 0.90 KDM4E (0.38) POLBKDM4EARF6ALDH1A1MEN1
SCHEMBL20914066 0.89 ARF6 (0.39) POLBKDM4EARF6ALDH1A1MEN1
SCHEMBL20914005 0.88 POLB (0.36) POLBKDM4EARF6ALDH1A1MEN1
SCHEMBL20914015 0.88 POLB (0.37) POLBKDM4EARF6ALDH1A1MEN1
SCHEMBL20914289 0.87 POLB (0.35) POLBKDM4EARF6ALDH1A1MEN1
SCHEMBL20914245 0.87 KDM4E (0.36) POLBKDM4EARF6ALDH1A1MEN1
SCHEMBL20914222 0.87 KDM4E (0.36) POLBKDM4EARF6ALDH1A1MEN1
SCHEMBL20819069 0.86 TNKS (0.37) POLBKDM4EARF6ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738056-B2 Pyrazolopyrimidinone compounds and uses thereof ADURO BIOTECH INC. (US) 2020-08-11 — — US disclosed
US-10738056-B2 Pyrazolopyrimidinone compounds and uses thereof ADURO BIOTECH INC. (US) 2020-08-11 — — US disclosed
US-20190119285-A1 PYRAZOLOPYRIMIDINONE COMPOUNDS AND USES THEREOF CHINOOK THERAPEUTICS, INC. 2019-04-25 — — US disclosed
US-20190119285-A1 PYRAZOLOPYRIMIDINONE COMPOUNDS AND USES THEREOF CHINOOK THERAPEUTICS, INC. 2019-04-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738056-B2 Pyrazolopyrimidinone compounds and uses thereof NLRP3, NLRP1, P2RX7 POLB 4311/4885KDM4E 1922/4885ARF6 3310/4885
US-20190119285-A1 PYRAZOLOPYRIMIDINONE COMPOUNDS AND USES THEREOF NLRP3, NLRP1, P2RX7 POLB 4311/4885KDM4E 1922/4885ARF6 3310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback